Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2026-03-09 @ 4:02 PM
Study NCT ID:
NCT03613402
Status:
WITHDRAWN
Last Update Posted:
2023-02-21
First Post:
2018-07-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes
Sponsor:
Portola Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-07-19
First Submit QC Date:
None
Study First Post Date:
2018-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-17
Last Update Post Date:
2023-02-21
Last Update Post Date Type:
ACTUAL